RecruitingNot Applicable

Study on Prognosis of Acutely Ruptured Intracranial Aneurysms

Netherlands880 participantsStarted 2021-07-14

Plain-language summary

The SPARTA study is a prospective multicenter observational trial in the Netherlands with the aim of identifying the best clinical care in patients with aneurysmal subarachnoidal haemorrhage. Differences in outcome between surgical treatment and endovascular treatment will be explored. Furthermore, cost effectiveness and radiological prognostic factors will be examined.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed diagnosis of subarachnoid haemorrhage on CT-scan or lumbar puncture (in the presence of a negative CT-scan) * Intracranial aneurysm proven within 6 months to be the cause of subarachnoid haemorrhage * Age 18 years or over at presentation. * Written informed consent Exclusion Criteria: * Subarachnoid haemorrhage deemed most likely of 'perimesencephalic' origin after consideration of history, clinical examination and radiological findings (including angiographic imaging) * Subarachnoid haemorrhage deemed most likely of post-traumatic origin after consideration of history, clinical examination and radiological findings (including angiographic imaging) * Diagnosis of intracerebral arteriovenous malformations or dural arteriovenous fistula. * No diagnosis of intracranial aneurysm at 6 months after onset of symptoms. * Not mastering the Dutch language

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The score on the modified Rankin Scale at 1 year after onset of symptoms.

Timeframe: 1 year after onset of symptoms

Trial details

NCT IDNCT05851989

SponsorHaaglanden Medical Centre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07-14

Contact for this trial

Rick Vreeburg, MD

+31(0)88-9792165 r.j.g.vreeburg@lumc.nl

View on ClinicalTrials.gov More Aneurysmal Subarachnoid Hemorrhage trials